Joe e pierce (29 Ergebnisse)

Zustand: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp.

Broschiert. Zustand: Gut. 102 Seiten; Das hier angebotene Buch stammt aus einer teilaufgelösten Bibliothek und kann entsprechende Kennzeichnungen aufweisen (Rückenschild, Instituts-Stempel.). Aufgrund des Alters und der häufigen Nutzung können Stabilität, Einband sowie Papierqualität beeinträchtigt sein. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 185.…

Broschiert. Zustand: Gut. 128 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sehr sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Einbandkanten sind leicht bestoßen. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 250.…

Hardcover. Zustand: Very Good. Zustand des Schutzumschlags: Very Good. Very good with very good dust jacket. Dust jacket is lightly bumped at spine tips and corners. Top corner of back cover and opposite inside corner of dust jacket are damp stained. 232 pages with index and 43 illustrations.

Zustand: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Zustand: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Zustand: Good. Good condition. Owner's name on inside cover. Writing inside. (Turkey).

Broschiert. Zustand: Gut. 188 Seiten; Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.); leichte altersbedingte Anbräunung des Papiers; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Einbandkanten sind leicht bestoßen. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 410.…

Softcover. Zustand: Gut. 145 S. Ehem. Bibliotheksexemplar mit Signatur und Stempel. GUTER Zustand, ein paar Gebrauchsspuren. Ex-library with stamp and library-signature. GOOD condition, some traces of use. y19388 913244058 Sprache: Englisch Gewicht in Gramm: 180.

Hardcover. Zustand: Fine. Zustand des Schutzumschlags: Good. [1st edition] ; 72 pp. ; 21 cm. ; LCCN: 62-48966 ; LC: PS559.A7; Dewey: 811.508 ; OCLC: 1815501 ; green cloth with gold lettering in spine-sunned dustjacket ; Poets featured include: Lowell Vance Benefield -- Susan D Ackiss -- Joe O. Basham -- Lois LeFevre Bennett -- Allan Bryant -- Kate Ford Codington -- George William Cooper, Sr. -- Maude Curtis -- Geneva Davies -- Mabel Dollar -- Irma Smith Dowis -- Geraldine W. Ferguson -- Sue Fife -- Marge Farris Gaissert -- Mary Belle Griffin -- Bea Han sard -- Gertrude Jones Hodnett -- Hazel Ware Hook -- Willette E. Hume -- John Ransom Lewis -- Carolyn Pierce Long -- Ellis Atkinson McDonald -- Ollie Reeves -- Florence M Rustin -- Kathy Sams -- Edna Danielson Stuebing -- George A. Taylor -- James E . Warren, Jr. -- Fred W. Wells -- Clifton A Wood. ; FINE/G. Book. …

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: New. In English.

Hardcover. Zustand: Brand New. 188 pages. 11.00x8.75x0.75 inches. In Stock.

Zustand: New. pp. 188.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - No detailed description available for 'Languages and linguistics'.

Zustand: DISCRETO USATO. Da revisionare INGLESE Copertina editoriale illustrata, parzialmente ingiallita, scolorita ai margini, con segni di pieghe in entrambi i piatti e agli angoli, etichetta e residuo di etichetta alla base dorso, strappi alla cima, all'interno pagine ingiallite ai bordi, con alcune illustrazioni in nero fuori testo, piega alle punte di alcune carte. Il volume potrebbe contenere timbri, il materiale à stato regolarmente acquisito dalla nostra Libreria. Numero pagine 102.…

Zustand: New. 1975. Hardcover. . . . . . Books ship from the US and Ireland.

hardcover. Zustand: Very Good. The copy shows minor external wear, but is otherwise in clean condition.

Zustand: New. In English.

Gebunden. Zustand: New.

Zustand: New. In English.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. Most blinding [CG1]diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.Significant advances in these areas of retinal degenerations have been made since the last RD Symposium, RD2021. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2023 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. Most blinding [CG1]diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.Significant advances in these areas of retinal degenerations have been made since the last RD Symposium, RD2021. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2023 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.…

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.…

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book contains the proceedings of the XVIII International Symposium on Retinal Degeneration (RD2018). A majority of those who spoke and presented posters at the meeting contributed to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium focused on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the 'best' and 'most important' meetings in the field.The volume presents representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy. While advances in these areas of retinal degenerations were described, there will be many new topics that either are in their infancy or did not exist at the time of the last RD Symposium. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials. The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases and neurodegenerations, in general. It should be noted that withsuccessful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those were reported at the RD2016 meeting and included in the current volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations is reflected in the volume.…

Hardcover. Zustand: Brand New. 538 pages. 10.00x7.00x10.00 inches. In Stock.

Hardcover. Zustand: Brand New. 607 pages. 10.00x7.01x1.31 inches. In Stock.

Paperback. Zustand: Good. First Edition. 72 pages. Features: 1960 Slates; Fort Lejeune fold-out cover illustration; and more. High Standard Manufacturing Corporation ad features photos of shooting prize winners Santiago Machuca, John C. Forman, David Cartes, Aubrey E. Smith, Roy Ratliff, and Richard Stineman; The Jet Age Wall - Are SAC and the ICBM offensive or defensive?; Embarkation Planning; The Marine Reserve; Peacetime Heroes; Report from the Ready Forces, The 2d Marine Division - Part I - Combat Readiness, and Part II - Programs to Improve Readienss; Write it Right; Your Ideas Wanted; The Salty Skipper; Brainstorming; Better Reserve Training; Sky Crane - the Sikorsky S-60; and more. Average wear. Unmarked. A sound vintage copy. Size: 4to - over 9¾" - 12" tall. Magazine.…